A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome

Merck Sharp & Dohme (MSD)

Status and phase: Terminated; Phase 3

Conditions: Pain

Treatments: Drug: MK0966; rofecoxib; Drug: Comparator: diclofenac, placebo

Study type: Interventional

Funder types: Industry

Identifiers

NCT00140933

2005_056

Details and patient eligibility

About

Comparing the short-term efficacy of rofecoxib versus placebo. Patients receive rofecoxib or placebo or diclofenac and fill out a patient diary on daytime pain severity during daily activities, night pain severity, and acetaminophen/paracetamol intake.

Sex: All

Ages: 18 to 59 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Males or females between the ages of 18 and 59 with acute painful rotator cuff syndrome.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind